Atlantic Research Group

What Atlantic Research Group does

Atlantic Research Group, Inc. (ARG) is a privately held, full-service contract research organization (CRO) founded in 2004 and headquartered in Charlottesville, Virginia, with additional offices in the United Kingdom, the Netherlands, Germany, Poland, Switzerland, and Australia. The company delivers Phase 1-3 and post-approval clinical trial services spanning clinical operations, medical monitoring, biostatistics and programming, data management, quality assurance, drug safety, regulatory affairs, decentralized clinical trial execution, rescue studies, retrospective studies, and legal representation. ARG serves small-to-mid-sized biotechnology and specialty pharmaceutical sponsors, with therapeutic depth in oncology, immunology, and neurology (notably ALS/MND), plus an expanding medical and biopharma technologies practice covering surgical and First-In-Man studies. Its technology stack combines Veeva Vault CTMS and Medrio EDC with secure Google Workspace environments that incorporate Gemini and NotebookLM Plus for generative AI-driven document summarization, brainstorming, eTMF filing automation, and trip report analysis.

ARG generates revenue through project-based professional services contracts and functional service provider (FSP) engagements priced on a quote basis, with no publicly disclosed rate cards. The go-to-market is enterprise field sales led by senior leadership including the CEO and President, supplemented by conference-driven relationship development (ASCO, AACR, NEALS, ENCALS, ALS Drug Development Summit), referral-driven growth from an 85% repeat-customer base, thought-leadership content (white papers, Xtalks webinars, SYNOPSIS newsletter), and patient advocacy community engagement. In July 2025, ARG merged with Kester Capital-backed Evestia Clinical to form an enlarged global specialist CRO, with ARG's CEO Paul Bishop and President Lyle Camblos joining the combined group's senior leadership team. Following the merger ARG operates as a subsidiary entity within the Evestia Clinical group, with founder-led continuity preserved across therapeutic areas and service lines.

Name

Atlantic Research Group

Legal name

Atlantic Research Group, Inc.

Website

https://atlanticresearchgroup.com

Company type

Private

Founded year

2004

Operating status

Acquired

Headcount range

51–100 employees

Short description

Atlantic Research Group is a privately held full-service CRO founded in 2004 that provides Phase 1-3 clinical trial services in oncology, immunology, neurology, and medical/biopharma technologies to small and mid-sized biotech and specialty pharma sponsors globally.

Ownership category

akta.pro rank

Product category

Contract Research Organization (Clinical Research Services)

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

akta.pro secondary industry

Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL)

Keywords

• Clinical research services
• Contract research organization
• Oncology clinical trials
• Rare disease drug development
• Biostatistics data management

Headquarters

HQ city

Charlottesville

HQ country

United States

HQ region

North America

Offices7 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Clinical Trial Services: ARG operates as a contract research organization (CRO) providing comprehensive clinical development services. Revenue is generated through project-based contracts for clinical trial management, monitoring, data management, biostatistics, regulatory services, and consulting. Services range from complete trial design and management to specialized functional service provider (FSP) solutions. The company offers both full-service engagements and customized functional service solutions.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels8 records

Core offering

Atlantic Research Group is a full-service contract research organization (CRO) that manages and executes clinical trials for biotechnology, specialty pharmaceutical, and medical technology companies. The company provides end-to-end clinical development services including clinical operations, medical monitoring, biostatistics, data management, drug safety, quality assurance, and regulatory support across oncology, immunology, neurology, and medical/biopharma technology therapeutic areas. ARG complements its core offerings with specialized services such as decentralized trials, rescue studies, retrospective studies, and legal representation for clinical research.

Product overview

Atlantic Research Group is a Contract Research Organization (CRO) providing comprehensive clinical trial services across multiple therapeutic areas. The company operates a platform of Signature Services (Clinical Operations, Medical Monitoring, Biostatistics, Quality Assurance, Data Management, Drug Safety, and Technologies) complemented by Unique Services (Decentralized Trials, Rescue Studies, Retrospective Studies, and Legal Representation). ARG focuses on three primary therapeutic areas: Oncology, Immunology, and Neurology (including rare diseases like ALS), plus Medical & Biopharma Technologies for surgical/interventional studies. The company offers specialized training programs like the ARG Oncology Academy and employs methodologies such as Risk-Based Quality Management (RBQM). ARG's approach emphasizes flexibility, patient-centricity, and the use of advanced technologies including AI tools for document analysis, workflow automation, and clinical data management.

Differentiator

Problem solved

Functional benefit

Products and services

• Signature Services

Quantifiable outcome

• 50+ market authorizations achieved
• +4 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability10 records

Feature4 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Evestia ClinicalcoreStrategic or Co-development Partner · 15 July 2025Evestia Clinical merged with Atlantic Research Group on July 15, 2025. The merger creates a leading independent global specialist CRO group, expanding Evestia Clinical's footprint in the US and broadening its therapeutic and services offering to include neurology and late-stage clinical trial services. The deal more than doubles the size of the Group by headcount and service delivery capability. ARG leadership team (CEO Paul Bishop and President Lyle Camblos) joins Evestia Clinical's senior leadership team.
• CytokineticscoreStrategic or Co-development Partner · 11 August 2021ARG serving as primary CRO for Cytokinetics' COURAGE-ALS Phase 3 clinical trial of Reldesemtiv. ARG has partnered with Cytokinetics for nearly a decade across 15 studies since 2005. The collaboration addresses ALS, a devastating neurodegenerative disease affecting over 200,000 people globally.
• Bio Products Laboratory (BPL)coreStrategic or Co-development Partner · 28 April 2021ARG established as preferred CRO vendor of record for BPL's global new product development programs. The agreement builds on successful prior clinical trial program collaboration and covers clinical trial and additional research support in coagulation disorders, immunology, and neurology, with options to extend based on performance and pipeline expansion.
• HumacytecoreStrategic or Co-development Partner · 1 January 2014ARG has provided full-service CRO support for Humacyte's Human Acellular Vessel (HAV) interposition graft program since 2014. Services included project management, data management, safety management, medical monitoring, and biostatistics. The collaboration resulted in successful BLA submission to FDA for vascular trauma indications.
• ADMA BiologicscoreStrategic or Co-development PartnerARG collaborated with ADMA Biologics since 2017 on IgG replacement therapy studies for Primary Immunodeficiency Disease. The partnership overcame enrollment challenges for pediatric patients and resulted in FDA approval of Bivigam for pediatric population (2 years and older) in December 2023.
• Virginia Economic Development Partnership (VEDP)minorGTM or Marketing PartnerARG participating in VEDP's VALET export trade program, leveraging the platform to build brand awareness and facilitate growth in the global marketplace. VEDP provides cachet and support for international expansion.

Scale indicators7 records

Recent moves11 records

Expansion highlights6 records

Direct peers

• Medpace: Mid-sized, therapeutically focused CRO with comparable headcount scale, biotech/specialty pharma customer mix, and emphasis on operational excellence and stable teams. Direct competitor for ARG's core oncology, rare disease, and specialty trial mandates.
• Worldwide Clinical Trials: Mid-tier global CRO specializing in CNS, oncology, and rare disease with a similar mid-sized, therapeutically focused model. Direct overlap with ARG's neurology/ALS franchise and biotech customer base.
• Premier Research: Specialty CRO with deep rare disease, oncology, and CNS focus serving small-to-mid biotechs. Highly comparable therapeutic specialization and customer profile to ARG.
• CTI Clinical Trial & Consulting Services: Mid-sized specialty CRO with therapeutic depth in rare/orphan diseases, oncology, and immunology. Comparable in size, scope, and biotech-focused customer base to ARG.
• Veristat: Mid-sized CRO focused on complex clinical trials for biopharma, including rare disease and oncology. Comparable positioning in the mid-tier specialty CRO segment.
• Clinipace Worldwide: Mid-sized, therapeutically aligned CRO serving small and mid-sized biopharma with oncology and specialty indications. Similar operating profile and customer segment to ARG.
• Ergomed: Specialty CRO and pharmacovigilance provider with rare disease and oncology focus, now owned by PE. Comparable mid-sized, therapeutically focused CRO model and customer overlap with ARG.

Broad incumbents

• ICON plc: Top-5 global full-service CRO with broad therapeutic coverage including oncology, neurology, and rare disease. Competes with ARG for biotech mandates but offers wider scale and functional service provider capabilities.
• IQVIA: Largest global CRO with full-service and biotech-focused franchises across all therapeutic areas. Competes with ARG on biotech trial RFPs but at a much larger scale and with broader technology/data assets.
• Parexel: Major global CRO with strong biotech and specialty pharma offering across oncology and rare disease. Larger, broader competitor that often competes with ARG on mid-sized biotech mandates.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCr9cRQ56OklEJ0-pWbFrVLQ
• Xx.com/argcro
• LinkedInlinkedin.com/company/atlantic-research-group

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Atlantic Research Group